Neurodegeneration: The Size Takes It All.
There is increasing computational evidence that the exceptionally high vulnerability of dopaminergic neurons in Parkinson's disease may be due to their unique axonal architecture and resulting metabolic needs. A new experimental study has actually demonstrated this.